NG

Naveen Galada

Active Director Director DIN 00592702
DIN 00592702 First appointment Jan 1999 Primary industry Chemicals and Materials
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 2 historical roles
Total affiliations 6 Since Jan 1999
Shareholding value •••• Premium profile

About Naveen Galada

Data last updated:

Naveen Galada is a Director at Leonid Chemicals Private Limited (since 1999), Designated Partner at Floradella Llp (since 2021) and Director at Avanthiya Pharma Private Limited (since 2021), and holds 1 more current directorship. The companies operate in Chemicals and Materials, Agriculture and Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹21.84 Cr; the largest is Leonid Chemicals Private Limited at ₹21.83 Cr (FY 2025). Earlier, Naveen Galada was a Designated Partner at Avanthiya Pharma Llp (from 2021) and Director at Pkv Pharmaceuticals Private Limited (from 2013).

DIN 00592702
Primary Designation Director
Industry Chemicals and Materials
First Appointment 21 Jan 1999
Oldest Company Age 27 yrs
Largest company Leonid Chemicals Private Limited · ₹21.83 Cr (FY 2025)
Combined revenue ₹21.84 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Leonid Chemicals Private Limited U24122KA1999PTC024646
Director21 Jan 19991999₹21.83 Cr (FY 2025)Active
Floradella Llp AAV-8708
Designated Partner12 Feb 20212021₹1 Lakh (FY 2026)Active
Avanthiya Pharma Private Limited U24100TN2021PTC148630
Director16 Dec 20212021₹15,000 (FY 2025)Active
Axxinovar Pharma Private Limited U24299TN2021PTC144629
Director08 Jul 20212021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner15 Jul 20212020Converted To Cmp And Dissolved
Pkv Pharmaceuticals Private Limited U24232KA2013FTC070735
Director28 Aug 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Floradella Llp
Avanthiya Pharma Llp
Avanthiya Pharma Private Limited
Leonid Chemicals Private Limited
Premium access

Shareholding and investment profile for Naveen Galada

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naveen Galada

Naveen Galada currently holds 4 directorships: Leonid Chemicals Private Limited (Director, since 21 Jan 1999, revenue ₹21.83 Cr (FY 2025)); Floradella Llp (Designated Partner, since 12 Feb 2021, revenue ₹1 Lakh (FY 2026)); Avanthiya Pharma Private Limited (Director, since 16 Dec 2021, revenue ₹15,000 (FY 2025)); Axxinovar Pharma Private Limited (Director, since 08 Jul 2021).

Naveen Galada was first appointed on 21 Jan 1999 as Director at Leonid Chemicals Private Limited. The most recent appointment on record is 16 Dec 2021 at Avanthiya Pharma Private Limited.

The 3 current companies of Naveen Galada that report revenue have a combined latest revenue of ₹21.84 Cr: Leonid Chemicals Private Limited ₹21.83 Cr (FY 2025); Floradella Llp ₹1 Lakh (FY 2026); Avanthiya Pharma Private Limited ₹15,000 (FY 2025).

Naveen Galada held 2 earlier board appointments: Avanthiya Pharma Llp (Designated Partner, from 15 Jul 2021); Pkv Pharmaceuticals Private Limited (Director, from 28 Aug 2013).

The current boards of Naveen Galada's companies include Dinesh Metha (Leonid Chemicals Private Limited), Mahavir Metha (Leonid Chemicals Private Limited), Ramesh Metha (Leonid Chemicals Private Limited), Veera Raghavan Venkatachalam (Leonid Chemicals Private Limited), Vinayak Nadiger (Leonid Chemicals Private Limited), Amith Bethala (Floradella Llp), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available